BASF Venture Capital and Orbio Ventures invest in Israeli biotech startup FortePhest

February 23, 2022 |

In Germany, BASF Venture Capital GmbH (BVC) and Orbia Ventures announce their Series-B investment in the Israeli biotech startup FortePhest. Founded in 2017, FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants. Inspired and informed by natural plant processes, the company supports crop protection on a global scale by implementing this technology. BASF Venture Capital and Orbia Ventures are joined by Sherpa InnoVentures, SIBF II and other investors for this funding round. Funding parties have agreed not to disclose the financial details of the investment.

The new technology aims to solve one of the most important challenges currently facing crop protection. As more than 250 weeds and invasive plant species are resistant to over 150 herbicides in use at present, innovative solutions are needed to meet the sustenance needs of a growing world population. By 2050, the world’s population will grow by about 2 billion to about 10 billion people while usable land for agriculture per person is anticipated to be reduced significantly and pesticide use will also be reduced as more countries adopt and implement sustainability policies. New plant protection products to improve crop yields whilst meeting sustainability requirements are therefore a critical focus of research.

FortePhest has pioneered the development of several classes of herbicides with a new mode of action to inhibit the growth of weeds, with no harm to high-value corn, wheat, and other important crops. FortePhest is developing proprietary herbicides (H-Forte) which disrupt the homeostasis of free amino acids in plant cells and selectively target a weed’s meristems, stopping developments of shoots and roots.

Category: Fuels

Thank you for visting the Digest.